1. Home
  2. SNY vs PANW Comparison

SNY vs PANW Comparison

Compare SNY & PANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • PANW
  • Stock Information
  • Founded
  • SNY 1994
  • PANW 2005
  • Country
  • SNY France
  • PANW United States
  • Employees
  • SNY N/A
  • PANW N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • PANW Computer peripheral equipment
  • Sector
  • SNY Health Care
  • PANW Technology
  • Exchange
  • SNY Nasdaq
  • PANW Nasdaq
  • Market Cap
  • SNY 120.2B
  • PANW 118.8B
  • IPO Year
  • SNY N/A
  • PANW 2012
  • Fundamental
  • Price
  • SNY $50.74
  • PANW $177.11
  • Analyst Decision
  • SNY Buy
  • PANW Buy
  • Analyst Count
  • SNY 2
  • PANW 43
  • Target Price
  • SNY $57.50
  • PANW $201.13
  • AVG Volume (30 Days)
  • SNY 2.3M
  • PANW 5.6M
  • Earning Date
  • SNY 01-30-2025
  • PANW 02-18-2025
  • Dividend Yield
  • SNY 4.01%
  • PANW N/A
  • EPS Growth
  • SNY N/A
  • PANW 332.61
  • EPS
  • SNY 4.00
  • PANW 3.85
  • Revenue
  • SNY $54,031,898,261.00
  • PANW $8,288,200,000.00
  • Revenue This Year
  • SNY $0.88
  • PANW $16.28
  • Revenue Next Year
  • SNY $6.28
  • PANW $15.43
  • P/E Ratio
  • SNY $25.52
  • PANW $46.05
  • Revenue Growth
  • SNY 6.01
  • PANW 15.00
  • 52 Week Low
  • SNY $45.22
  • PANW $130.05
  • 52 Week High
  • SNY $58.97
  • PANW $207.24
  • Technical
  • Relative Strength Index (RSI)
  • SNY 63.19
  • PANW 42.56
  • Support Level
  • SNY $47.88
  • PANW $166.21
  • Resistance Level
  • SNY $51.08
  • PANW $175.24
  • Average True Range (ATR)
  • SNY 0.66
  • PANW 4.63
  • MACD
  • SNY 0.29
  • PANW -0.26
  • Stochastic Oscillator
  • SNY 89.67
  • PANW 52.40

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About PANW Palo Alto Networks Inc.

Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three fourths of the Global 2000.

Share on Social Networks: